Study Tamoxifen May Raise Risk Of Aggressive Tumor
08.26.09 |
A widely used drug to prevent the reoccurrence of breast cancer has a risk of a hidden and even more deadly side effect. A study appearing Tuesday in "Cancer Research" questions the drug Tamoxifen, which reduces the spread of estrogen-sensitive cancers.
The study showed that women taking Tamoxifen were four times more likely to develop a non-estrogen-sensitive tumor. But medical experts question the findings, saying the drug has many more positive benefits than risks.
Tweet
CATEGORIES
AUTHORS
ARCHIVE BY MONTH
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008